GVHD characteristics
| . | n . | % . |
|---|---|---|
| Acute GVHD severity | ||
| Grade 1 | 4 | 11 |
| Grade 2 | 9 | 25 |
| Grade 3 | 2 | 6 |
| Grade 4 | 2 | 6 |
| Acute GVHD organ involvement | ||
| Skin | 9 | 25 |
| GI tract | 4 | 11 |
| GI tract + skin | 2 | 6 |
| GI tract + liver ± skin | 2 | 6 |
| Severity of chronic GVHD* | ||
| Mild | 2 | 6 |
| Moderate | 9 | 25 |
| Severe | 1 | 3 |
| . | n . | % . |
|---|---|---|
| Acute GVHD severity | ||
| Grade 1 | 4 | 11 |
| Grade 2 | 9 | 25 |
| Grade 3 | 2 | 6 |
| Grade 4 | 2 | 6 |
| Acute GVHD organ involvement | ||
| Skin | 9 | 25 |
| GI tract | 4 | 11 |
| GI tract + skin | 2 | 6 |
| GI tract + liver ± skin | 2 | 6 |
| Severity of chronic GVHD* | ||
| Mild | 2 | 6 |
| Moderate | 9 | 25 |
| Severe | 1 | 3 |
GI, gastrointestinal; ±, with or without.
Minimum follow-up of 100 days post-HCT.